Outset Medical (OM) Debt to Equity (2019 - 2025)
Outset Medical (OM) has disclosed Debt to Equity for 7 consecutive years, with $0.76 as the latest value for Q4 2025.
- On a quarterly basis, Debt to Equity fell 89.7% to $0.76 in Q4 2025 year-over-year; TTM through Dec 2025 was $0.76, a 89.7% decrease, with the full-year FY2025 number at $0.76, down 89.7% from a year prior.
- Debt to Equity was $0.76 for Q4 2025 at Outset Medical, up from $0.67 in the prior quarter.
- In the past five years, Debt to Equity ranged from a high of $7.36 in Q4 2024 to a low of $0.07 in Q2 2021.
- A 5-year average of $1.14 and a median of $0.54 in 2023 define the central range for Debt to Equity.
- Peak YoY movement for Debt to Equity: surged 595.07% in 2024, then plummeted 89.7% in 2025.
- Outset Medical's Debt to Equity stood at $0.08 in 2021, then surged by 392.24% to $0.39 in 2022, then soared by 170.36% to $1.06 in 2023, then soared by 595.07% to $7.36 in 2024, then tumbled by 89.7% to $0.76 in 2025.
- Per Business Quant, the three most recent readings for OM's Debt to Equity are $0.76 (Q4 2025), $0.67 (Q3 2025), and $0.61 (Q2 2025).